Lymphoma is divided into Hodgkin’s lymphoma and non-Hodgkin’s lymphoma, and chemotherapy regimens vary by pathological type. For example, the chemotherapy regimens for patients with Hodgkin’s lymphoma are: i. ABVD regimen, which mainly consists of adriamycin, bleomycin, vincristine, and dacarbazine; ii. ICE regimen, which consists of isocyclophosphamide, carboplatin, and pedialyte glycosides; iii. DHAP regimen, which consists of dexamethasone, cisplatin, and cytarabine; and others have ESHAP regimen. For patients with non-Hodgkin’s lymphoma the commonly applied regimen is the CHOP regimen, consisting mainly of cyclophosphamide, adriamycin, vincristine, and prednisone; the COP regimen consists mainly of cyclophosphamide, vincristine, and prednisone. In addition, if CD20 positive, anti-CD20 monoclonal antibody, also known as melphalan, can be applied for treatment; there are also Hyper-CVAD regimens such as regimen A and regimen B.